logo

For the Inventor, By the Inventor

Budapest, Hungary

Ferenc Andrasi

This inventor holds 21 USPTO granted patents, primarily in Benzodiazepine Derivatives. Top assignees: Gyogyszerkutato Intezet Kft., Egis Gyogyszergyar, Egis Gyogyszergyar Rt.. Active years: 1976-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ferenc Andrasi. Retrieved from https://idiyas.com/inventor/ferenc-andrasi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21

% Patents Active = 95.2

Average Co-Inventor Count = 10.1

ph-index = 8

Forward Citations = 259(Granted Patents)


Company Filing History:

goldMedal5 out of 13 
 
Gyogyszerkutato Intezet Kft.
 patents
silverMedal2 out of 46 
 
Egis Gyogyszergyar
 patents
bronzeMedal2 out of 33 
 
Egis Gyogyszergyar Rt.
 patents
4. 2 out of 6 
 
Gyogyszerkutato Intezet
 patents
5. 2 out of 1,409 
 
Schering Aktiengesellschaft
 patents
6. 1 out of 24 
 
Alkaloida Vegyeszeti Gyar
 patents
7. 1 out of 19 
 
Biogal Gyogyszergyar
 patents
8. 1 out of 1 
 
Cyogyszerkutato Intezet Kft
 patent
9. 1 out of 62 
 
Egyt Gyogyszervegyeszeti Gyar
 patents
10. 1 out of 1 
 
Gis Gyogyszergyar Rt.
 patent
11. 1 out of 1 
 
Gyogyszerkutato Intezet Kv.
 patent
12. 1 out of 3 
 
Ivax Drug Research Institute
 patents
13. 1 out of 346 
 
Richter Gedeon Vegyeszeti Gyar Rt
 patents

Years Active: 1976-2003

Loading Chart...
Areas of Expertise:
Benzodiazepine
AMPA-Receptor
Pharmaceutical Compositions
Piperazine
Thiouracyl
Anorexigenic
Acylated Aminothiazole
Spiral Derivatives
21 patents (USPTO):Explore Patents
1. 6602865 - Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone and -diazepinone compounds (2003-08-05),
2. 6600036 - Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors (2003-07-29),
3. 6075018 - 1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine (2000-06-13),
4. 5942506 - 1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives (1999-08-24),
5. 5854250 - N-benzoylamino acid derivatives, pharmaceutical compositions containing (1998-12-29),
6. 5807851 - 2,3-Benzodiazepine Derivatives as non-competitive AMPA (1998-09-15),
7. 5756495 - 3-substituted 3H-2, 3-benzodiazepine derivatives, the production and use (1998-05-26),
8. 5705529 - N-benzoyl amino acid derivatives pharmaceutical compositions containing (1998-01-06),
9. 5639751 - N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic (1997-06-17),
10. 5536832 - N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions (1996-07-16),
11. 5521174 - N-acyl-2,3-benzodiazepine derivatives and a method of treating spasms of (1996-05-28),
12. 5519019 - N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions (1996-05-21),
13. 5459137 - N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions (1995-10-17),
14. 5380724 - Piperazine and homopiperazine derivatives, pharmaceutical compositions (1995-01-10),
15. 5204343 - 5H-benzodiazepin derivative (1993-04-20),

Title: The Inventor Spotlight: Ferenc Andrasi

Introduction: Ferenc Andrasi, a prolific inventor hailing from Budapest, Hungary, has made significant contributions to the field of pharmaceuticals with over 21 patents to his name.

Latest Patents: Among his recent innovations are patents for Pyridazino(4,5-b)(1,5)oxazepinone, -thiazepinone, and -diazepinone compounds, Condensed 2,3-benzodiazepine derivatives used as AMPA-receptor inhibitors, and Compounds of formula I for pharmaceutical agent applications.

Career Highlights: Ferenc Andrasi has demonstrated his expertise while working at Gyógyszerkutató Intézet Kft. and Gyógyszerkutató Intézet, showcasing his dedication to advancing pharmaceutical research and development.

Collaborations: Throughout his career, Ferenc Andrasi has collaborated closely with esteemed colleagues such as Pal Berzsenyi and Tamas Hamori, fostering a dynamic environment for innovation and discovery in the pharmaceutical industry.

Conclusion: Ferenc Andrasi's remarkable journey as an inventor underscores his passion for pushing boundaries in pharmaceutical research, resulting in groundbreaking patents that have the potential to shape the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…